Advanced pain discovery platform: frequently asked questions

A list of anticipated questions about the advanced pain discovery platform opportunity, along with answers.



Advanced pain discovery platform: frequently asked questions (PDF)

, 186 KB

If you cannot open or read this document, you can ask for a different format.

Request a different format

Email, telling us:

  • the name of the document
  • what format you need
  • any assistive technology you use (such as type of screen reader).

Find out about our approach to the accessibility of our website.


The questions and answers covered in detail are:

  • what is the remit of this call in terms of disease conditions, age groups and translational versus basic research?
  • what is the anticipated structure of a consortium and who can participate?
  • what and who can be included in the consortium bid?
  • how will the different phases of the APDP be funded?
  • how will the consortia be evaluated?
  • how are the consortia expected to interact with each other?
  • how can we get involved in consortia applications?
  • how will the recent COVID-19 outbreak affect the consortia call?

This is the website for UKRI: our seven research councils, Research England and Innovate UK. Let us know if you have feedback or would like to help improve our online products and services.